InvestorsHub Logo
Followers 3
Posts 155
Boards Moderated 0
Alias Born 09/24/2018

Re: sstyles post# 228728

Wednesday, 11/20/2019 11:07:27 AM

Wednesday, November 20, 2019 11:07:27 AM

Post# of 425940
I actually think the Oppenheimer report was more to try to elevate ACST than to try to hit us. ACST has a load of outstanding warrants at prices lower than current stock price. They are also down to their last $25million in cash and burned through $28 million last quarter. Keep stock price up, let warranty holders execute and sell on market. This raises cash for the company and allows a profit for the warranty holders. Only way to get enough publicity is to tie it to something big in the news currently - AMRN. I suspect the weakness in ACST stock today is all the warrants being exercised and sold, plus potentially stock options. Average investor believing analyst is unconflicted gets left holding the can. Reminds me of Henry Blodget during dot com days as Merrill Lynch analyst.

If AMRN was truly worried about ACST as a competitor they could just buy them. ACST has a market cap of around $200 million and AMRN has $600 million in bank.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News